Antabuse, a drug commonly prescribed to treat alcohol use disorder, may help to restore eyesight in people with genetic retinitis pigmentosa and other disorders associated with retinal degeneration.
If the circadian clock is disrupted, we might be at greater risk of retinal degeneration as we age.
The ability of retinal cells to "wall off" damage may be key to preserving vision.
Age-related macular degeneration and lupus share a common contributor to inflammation. The findings could help researchers develop new treatments for those conditions, and other conditions associated with inflammation.
A newly designed bionic eye is safe and stable for long-term implantation, researchers conclude following a three-month study in sheep. The discovery paves the way for human trials of the bionic device.
A once-weekly three-minute exposure to long-wave deep red light activates mitochondria in the retina, helping to naturally boost declining vision.
Fluoxetine, the antidepressant commonly known as Prozac, may be beneficial for the treatment of age-related macular degeneration. Researchers found Prozac significantly slowed the rate at which people over 50 developed AMD.
Researchers created a form of artificial vision for a blind woman with the aid of a brain implant position in the visual cortex. The results pave the way for the creation of visual brain prosthetics to help the blind to regain sight.
Contrary to popular belief, a child's visual perception does not reach adult level at age seven. A new study reveals children's visual perception continues to develop and does not reach maturity until age ten.
Findings upend the long-standing belief that blind people lack deep knowledge of visual phenomena.
Perception of social interactions unfolds through pupil dilation. The findings shed light on the visual system's role in sensitivity to social interactions.
Study reveals very young infants can perceive objects that older infants, children, and adults can not see due to a phenomenon called visual backward masking.
